Affiliation:
1. TURGUT OZAL UNIVERSITY
2. MUS ALPARSLAN UNIVERSITY
Abstract
Dexamethasone is a synthetic adrenal corticosteroid with potent anti-inflammatory properties. Dexamethasone (MK-125) is a position 9 fluorinated corticosteroid used to treat endocrine, rheumatic, collagen, dermatological, allergic, ophthalmic, gastrointestinal, respiratory, hematological, neoplastic, edematous, and other conditions. On June 16, 2020, a press release for the Randomized Evaluation of COVID-19 Treatment (RECOVERY) trial recommended the use of dexamethasone in COVID-19 patients with severe respiratory symptoms. Dexamethasone reduced deaths by approximately one-third in ventilated patients and one-fifth in patients requiring oxygen. Therefore, Dexamethasone is used in the treatment of COVID-19 patients in some countries. In this study, we researched the spectroscopic and photonic properties of Dexamethasone. We have extensively studied the absorption spectra at different concentrations and their response to light. This study shows the absorbance spectra of the Dexamethasone for various concentrations. On the other hand, we continue to work intensively on some herbal suggestions that can be considered equivalent to Dexamethasone.
Publisher
Journal of Physical Chemistry and Functional Materials
Reference17 articles.
1. https://pubchem.ncbi.nlm.nih.gov/compound/Dexamethasone.
2. Bunim, J.J., Black, R.L., Lutwak, L., Peterson, R.E. and Whedon, G.D. (1958), Studies on dexamethasone, a new synthetic steroid, in rheumatoid arthritis—a preliminary report. Arthritis & Rheumatism, 1: 313-331.
3. The American Society of Health-System Pharmacists. Archived from the original on 31 August 2017. Retrieved 29 July 2015 (https://en.wikipedia.org/wiki/Dexamethasone#cite_note-AHFS2015-10).
4. George, P. M., Wells, A. U. & Jenkins, R. G. Lancet Respir. Med. https://doi.org/10.1016/S2213-2600(20)30225-3 (2020).
5. Lammers, T., Sofias, A.M., Van der Meel, R., Schiffelers, R., Storm, G., Tacke, F., Koschmieder, S., Brümmendorf, T.H., Kiessling, F., Metselaar, J. (2020). Dexamethasone nanomedicines for COVID-19. Nat. Nanotechnol. 15, 622–624. https://doi.org/10.1038/s41565-020-0752-z